EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 135 filers reported holding EPIZYME INC in Q2 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $100,000 | +12.4% | 87,293 | +146.6% | 0.00% | – |
| Q4 2021 | $89,000 | -53.2% | 35,402 | -4.8% | 0.00% | – |
| Q3 2021 | $190,000 | -96.7% | 37,172 | -94.7% | 0.00% | -100.0% |
| Q2 2021 | $5,812,000 | -7.4% | 699,480 | -2.9% | 0.01% | -15.4% |
| Q1 2021 | $6,274,000 | -30.9% | 720,291 | -13.9% | 0.01% | -27.8% |
| Q4 2020 | $9,080,000 | -15.9% | 836,125 | -7.6% | 0.02% | -25.0% |
| Q3 2020 | $10,792,000 | +14.6% | 904,523 | +54.2% | 0.02% | +9.1% |
| Q2 2020 | $9,420,000 | +9.6% | 586,567 | +5.9% | 0.02% | -4.3% |
| Q1 2020 | $8,591,000 | -11.1% | 553,913 | +41.0% | 0.02% | +15.0% |
| Q4 2019 | $9,666,000 | +43.8% | 392,923 | -39.7% | 0.02% | +33.3% |
| Q3 2019 | $6,722,000 | +91.7% | 651,683 | +133.3% | 0.02% | +87.5% |
| Q2 2019 | $3,506,000 | -57.1% | 279,362 | -57.7% | 0.01% | -55.6% |
| Q1 2019 | $8,178,000 | -4.0% | 660,128 | -52.3% | 0.02% | -14.3% |
| Q4 2018 | $8,518,000 | -55.0% | 1,382,691 | -22.6% | 0.02% | -46.2% |
| Q3 2018 | $18,942,000 | +18.2% | 1,786,978 | +51.1% | 0.04% | +14.7% |
| Q2 2018 | $16,029,000 | +48.9% | 1,182,983 | +95.0% | 0.03% | +47.8% |
| Q1 2018 | $10,766,000 | +42.2% | 606,547 | +0.6% | 0.02% | +43.8% |
| Q4 2017 | $7,569,000 | -34.3% | 603,131 | -0.3% | 0.02% | -36.0% |
| Q3 2017 | $11,527,000 | +40.5% | 605,089 | +11.3% | 0.02% | +38.9% |
| Q2 2017 | $8,207,000 | -1.5% | 543,474 | +11.9% | 0.02% | -5.3% |
| Q1 2017 | $8,330,000 | -19.8% | 485,671 | -43.4% | 0.02% | -24.0% |
| Q4 2016 | $10,388,000 | +20.3% | 858,599 | -2.2% | 0.02% | +56.2% |
| Q3 2016 | $8,637,000 | +5166.5% | 877,720 | +5387.5% | 0.02% | – |
| Q2 2016 | $164,000 | 0.0% | 15,995 | +18.2% | 0.00% | – |
| Q1 2016 | $164,000 | -24.4% | 13,531 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $217,000 | +24.7% | 13,531 | 0.0% | 0.00% | – |
| Q3 2015 | $174,000 | -46.5% | 13,531 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $325,000 | +54.0% | 13,531 | +73.5% | 0.00% | – |
| Q3 2014 | $211,000 | -13.2% | 7,801 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $243,000 | – | 7,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |